BackAbbvie Overview

Abbvie Minority Interest

Abbvie's minority interest is $47M.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$47.00M
↑ 4.44% YoYΔ $2.00M vs prior year quarter

Peer average / median

Loading

Abbvie Minority Interest History

Loading

Abbvie vs. peers: Minority Interest Comparison

Loading

Abbvie Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Abbvie (ABBV) FAQ

As of the most recent data (June 2026), ABBV shows a minority interest of $47M. That compares with $45M in the prior-year period — up 4.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ABBV's minority interest is now $47M (was $45M) — a 4.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Abbvie is outperforming or lagging.

Tracking ABBV's minority interest over time shows whether Abbvie is scaling, shrinking, or reshaping that part of the business. The current reading is $47M That compares with $45M in the prior-year period — up 4.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Abbvie's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $47M) with ownership activity and broader fundamentals.

Abbvie's minority interest is $47M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.